NDC Pharmacologic Class N0000193542 Vascular Endothelial Growth Factor Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0024-5840Zaltrap Ziv-afliberceptSolution, ConcentrateIntravenousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5841Zaltrap Ziv-afliberceptSolution, ConcentrateIntravenousSanofi-aventis U.s. LlcHuman Prescription Drug
50242-060Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.Human Prescription Drug
50242-061Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.Human Prescription Drug
50242-080Lucentis RanibizumabInjection, SolutionIntravitrealGenentech, Inc.Human Prescription Drug
50242-082Lucentis RanibizumabInjection, SolutionIntravitrealGenentech, Inc.Human Prescription Drug
55513-206Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncHuman Prescription Drug
55513-207Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncHuman Prescription Drug
61755-005Eylea AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, Inc.Human Prescription Drug

There are 9 NDC products with the pharmacologic class Vascular Endothelial Growth Factor Inhibitors [MoA].